NIH #R43CA102804
Development of antagonists for oncogenic K+ channel KCNB
- Amount
- $200K–$300K
- Period
- 2003-08-11 → 2004-06-30
- PIs
- 1
Awarded at TULARIK, INC.
Cancer Cells and Metastasis · Oncology
Compare more Oncology professors.
1 total · 0 active
NIH #R43CA102804
Awarded at TULARIK, INC.
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data may not be current
ORCID: 0000-0001-7066-015X